Loading live market data…

Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

$41.4038 USD

$0.23 (0.57%)

Volume
90.4K
Average Volume
400.07K
Market Capitalization
$766.06M
P/E Ratio
2.06
Dividend Yield
0.00%
Price Target
$38.00
Year High
$52.24
Year Low
$18.66
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.62

RIGL Estimated and Actual Revenue by Quarter

RIGL Estimated and Actual EPS by Quarter

RIGL Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 -1.26M -1.16M -1.21M -2.21M -2.03M -2.12M
2027-09-30 2 -1.19M -1.09M -1.14M -2.09M -1.92M -2M
2027-06-30 2 -1.11M -1.02M -1.06M -1.94M -1.78M -1.86M
2027-03-31 1 -1.02M -938.11K -979.32K -1.79M -1.64M -1.72M
2026-12-31 2 -1.09M -1M -1.04M -1.91M -1.75M -1.83M
2026-09-30 3 -996.95K -974.5K -985.72K -1.75M -1.71M -1.73M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 22.33M 24.93M 23.62M 64.19M 69.87M 67.01M
2027-09-30 2 18.98M 21.19M 20.08M 60.57M 65.92M 63.23M
2027-06-30 2 17.21M 19.22M 18.21M 56.29M 61.27M 58.77M
2027-03-31 1 12.38M 13.82M 13.09M 51.98M 56.57M 54.26M
2026-12-31 2 21.62M 24.14M 22.88M 55.46M 60.36M 57.9M
2026-09-30 3 20.07M 25.74M 22.9M 53.99M 55.24M 54.61M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 92.23M 100.38M 96.28M 1 1.13435 1.26636 1.2
2027-09-30 2 87.02M 94.7M 90.84M 1 0.9642 1.07641 1.02
2027-06-30 2 80.88M 88.02M 84.43M 1 0.87439 0.97615 0.925
2027-03-31 1 74.67M 81.27M 77.96M 1 0.62862 0.70178 0.665
2026-12-31 2 79.68M 86.72M 83.18M 1 1.09849 1.22632 1.16206
2026-09-30 3 77.57M 79.36M 78.47M 3 1.01933 1.30741 1.16337